细针穿刺细胞学检查(fine needle aspirationcytology,FNAC)是一种成熟的诊断肝脏肿瘤的方法。但这种方法有其公认的并发症,用于腹部肿瘤诊断时可导致0.006％-0.031％的患者死亡。大部分死亡患者为肝脏肿瘤,死亡原因为出血。另一并发症为肿瘤沿活检针道转移,但其发生率较低为0.003％-0.07％,多见于胰腺肿瘤。最近有报道FNAC用于肝脏病变(通常是原发性肝癌)时,循针道转移的概率明显升高(0.4％-5.1％)。 Fine needle aspiration cytology (FNAC) is a mature method of diagnosing liver tumors. However, this method has its own recognized complication, which can lead to the death of 0.006% -0.031% of patients in the diagnosis of abdominal tumors. Most of the patients died of liver tumors, the cause of death was bleeding. Another complication of tumor biopsy needle transfer, but the incidence was low 0.003% -0.07%, more common in pancreatic tumors. It has recently been reported that FNAC has a markedly increased probability of needle-to-needle metastasis (0.4% -5.1%) for liver lesions (usually primary liver cancer).